9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cancer associated fibroblasts (CAFs) constitute an abundant stromal component of most solid tumors. Fibroblast activation protein (FAP) α is a cell surface protease that is expressed by CAFs. We corroborate this expression profile by immunohistochemical analysis of colorectal cancer specimens. To better understand the tumor‐contextual role of FAPα, we investigate how FAPα shapes functional and proteomic features of CAFs using loss‐ and gain‐of function cellular model systems. FAPα activity has a strong impact on the secreted CAF proteome (“secretome”), including reduced levels of anti‐angiogenic factors, elevated levels of transforming growth factor (TGF) β, and an impact on matrix processing enzymes. Functionally, FAPα mildly induces sprout formation by human umbilical vein endothelial cells. Moreover, loss of FAPα leads to a more epithelial cellular phenotype and this effect was rescued by exogenous application of TGFβ. In collagen contraction assays, FAPα induced a more contractile cellular phenotype. To characterize the proteolytic profile of FAPα, we investigated its specificity with proteome‐derived peptide libraries and corroborated its preference for cleavage carboxy‐terminal to proline residues. By “terminal amine labeling of substrates” (TAILS) we explored FAPα‐dependent cleavage events. Although FAPα acts predominantly as an amino‐dipeptidase, putative FAPα cleavage sites in collagens are present throughout the entire protein length. In contrast, putative FAPα cleavage sites in non‐collagenous proteins cluster at the amino‐terminus. The degradomic study highlights cell‐contextual proteolysis by FAPα with distinct positional profiles. Generally, our findings link FAPα to key aspects of CAF biology and attribute an important role in tumor–stroma interaction to FAPα.

          Highlights

          • We investigated the secretome and degradome of CAFs with FAPα loss‐ and gain‐of‐function.

          • FAPα controls levels of secreted proteins linked to TGFβ signaling, angiogenesis and matrix remodeling.

          • Functional studies substantiate a role of FAPα in TGFβ signaling, angiogenesis and matrix remodeling.

          • We corroborated the specificity of FAPα for P1 proline using proteome‐derived peptide libraries.

          • First FAPα substrate candidates were identified.

          Related collections

          Author and article information

          Contributors
          oliver.schilling@mol-med.uni-freiburg.de
          Journal
          Mol Oncol
          Mol Oncol
          10.1002/(ISSN)1878-0261
          MOL2
          Molecular Oncology
          John Wiley and Sons Inc. (Hoboken )
          1574-7891
          1878-0261
          11 August 2015
          January 2016
          : 10
          : 1 ( doiID: 10.1002/mol2.2016.10.issue-1 )
          : 40-58
          Affiliations
          [ 1 ]Institute of Molecular Medicine and Cell Research, University of Freiburg, D-79104 Freiburg, Germany
          [ 2 ]University Eye Hospital Freiburg, Killianstrasse 5, 79106 Freiburg, Germany
          [ 3 ]Institute of Surgical Pathology, Department of Pathology, University Medical Center, Freiburg, Germany
          [ 4 ]Centre for Blood Research, University of British Columbia, Vancouver, BC V6T 1Z3, Canada
          [ 5 ]Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada
          [ 6 ]Department of Chemistry, University of British Columbia, Vancouver, BC V6T 1Z3, Canada
          [ 7 ]Laboratory of Experimental Cancer Research, Ghent University Hospital, 1P7, De Pintelaan 185, 9000 Gent, Belgium
          [ 8 ]Clinic for Surgery, UKSH Campus Lübeck, Lübeck, Germany
          [ 9 ]BIOSS Centre for Biological Signaling Studies, University of Freiburg, D-79104 Freiburg, Germany
          [ 10 ]German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
          Author notes
          [*] [* ]Corresponding author. Stefan Meier Strasse 17, 79104 Freiburg, Germany. Tel.: +49 761 203 9615.
          Article
          PMC5528924 PMC5528924 5528924 MOL2201610140
          10.1016/j.molonc.2015.08.001
          5528924
          26304112
          2f58e02a-ae89-4554-ad29-ac1082188e96
          © 2016 Federation of European Biochemical Societies
          History
          : 06 May 2015
          : 24 July 2015
          : 03 August 2015
          Page count
          Figures: 11, Tables: 1, Equations: 0, References: 127, Pages: 19, Words: 13342
          Categories
          Article
          Articles
          Custom metadata
          2.0
          mol2201610140
          January 2016
          Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.4 mode:remove_FC converted:25.07.2017

          FAPα,CAFs,Secretome,Degradome,Angiogenesis,TGFβ
          FAPα, CAFs, Secretome, Degradome, Angiogenesis, TGFβ

          Comments

          Comment on this article